nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—kidney cancer—melanoma	0.738	1	CtDrD
Capecitabine—TYMS—Paclitaxel—Docetaxel—melanoma	0.0022	1	CbGdCrCtD
Capecitabine—TYMP—endothelium—melanoma	0.00135	0.162	CbGeAlD
Capecitabine—TYMP—blood vessel—melanoma	0.00125	0.149	CbGeAlD
Capecitabine—CDA—mammalian vulva—melanoma	0.000873	0.105	CbGeAlD
Capecitabine—CES1—neck—melanoma	0.000769	0.0922	CbGeAlD
Capecitabine—TYMP—mammalian vulva—melanoma	0.000526	0.063	CbGeAlD
Capecitabine—TYMS—skin of body—melanoma	0.000495	0.0593	CbGeAlD
Capecitabine—DPYD—lymph node—melanoma	0.000455	0.0545	CbGeAlD
Capecitabine—TYMS—mammalian vulva—melanoma	0.000451	0.0541	CbGeAlD
Capecitabine—CDA—lymph node—melanoma	0.000437	0.0524	CbGeAlD
Capecitabine—TYMP—head—melanoma	0.000376	0.0451	CbGeAlD
Capecitabine—CES1—head—melanoma	0.000325	0.0389	CbGeAlD
Capecitabine—TYMS—head—melanoma	0.000323	0.0387	CbGeAlD
Capecitabine—TYMP—lymph node—melanoma	0.000263	0.0316	CbGeAlD
Capecitabine—CES1—lymph node—melanoma	0.000227	0.0273	CbGeAlD
Capecitabine—TYMS—lymph node—melanoma	0.000226	0.0271	CbGeAlD
Capecitabine—Chills—Temozolomide—melanoma	0.000126	0.000695	CcSEcCtD
Capecitabine—Dehydration—Docetaxel—melanoma	0.000125	0.000693	CcSEcCtD
Capecitabine—Ill-defined disorder—Dactinomycin—melanoma	0.000125	0.000692	CcSEcCtD
Capecitabine—Anaemia—Dactinomycin—melanoma	0.000125	0.000689	CcSEcCtD
Capecitabine—Liver function test abnormal—Docetaxel—melanoma	0.000125	0.000688	CcSEcCtD
Capecitabine—Vomiting—Vemurafenib—melanoma	0.000124	0.000685	CcSEcCtD
Capecitabine—Alopecia—Temozolomide—melanoma	0.000124	0.000685	CcSEcCtD
Capecitabine—Dry skin—Docetaxel—melanoma	0.000124	0.000683	CcSEcCtD
Capecitabine—Chest pain—Bleomycin—melanoma	0.000123	0.000681	CcSEcCtD
Capecitabine—Myalgia—Bleomycin—melanoma	0.000123	0.000681	CcSEcCtD
Capecitabine—Abdominal pain upper—Docetaxel—melanoma	0.000123	0.00068	CcSEcCtD
Capecitabine—Orthostatic hypotension—Docetaxel—melanoma	0.000123	0.00068	CcSEcCtD
Capecitabine—Rash—Vemurafenib—melanoma	0.000123	0.000679	CcSEcCtD
Capecitabine—Mental disorder—Temozolomide—melanoma	0.000123	0.000679	CcSEcCtD
Capecitabine—Dermatitis—Vemurafenib—melanoma	0.000123	0.000678	CcSEcCtD
Capecitabine—Back pain—Carmustine—melanoma	0.000122	0.000675	CcSEcCtD
Capecitabine—Headache—Vemurafenib—melanoma	0.000122	0.000675	CcSEcCtD
Capecitabine—Erythema—Temozolomide—melanoma	0.000122	0.000674	CcSEcCtD
Capecitabine—Malnutrition—Temozolomide—melanoma	0.000122	0.000674	CcSEcCtD
Capecitabine—Breast disorder—Docetaxel—melanoma	0.000122	0.000673	CcSEcCtD
Capecitabine—Discomfort—Bleomycin—melanoma	0.000122	0.000673	CcSEcCtD
Capecitabine—Malaise—Dactinomycin—melanoma	0.000122	0.000672	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000122	0.000671	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000122	0.000671	CcSEcCtD
Capecitabine—Leukopenia—Dactinomycin—melanoma	0.000121	0.000667	CcSEcCtD
Capecitabine—Nasopharyngitis—Docetaxel—melanoma	0.000121	0.000666	CcSEcCtD
Capecitabine—Dysgeusia—Temozolomide—melanoma	0.00012	0.00066	CcSEcCtD
Capecitabine—Confusional state—Bleomycin—melanoma	0.000119	0.000658	CcSEcCtD
Capecitabine—Vision blurred—Carmustine—melanoma	0.000119	0.000658	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000119	0.000657	CcSEcCtD
Capecitabine—Tremor—Carmustine—melanoma	0.000118	0.000654	CcSEcCtD
Capecitabine—Oedema—Bleomycin—melanoma	0.000118	0.000653	CcSEcCtD
Capecitabine—Back pain—Temozolomide—melanoma	0.000118	0.000652	CcSEcCtD
Capecitabine—Infection—Bleomycin—melanoma	0.000117	0.000648	CcSEcCtD
Capecitabine—Anaemia—Carmustine—melanoma	0.000117	0.000645	CcSEcCtD
Capecitabine—Dysphagia—Docetaxel—melanoma	0.000117	0.000644	CcSEcCtD
Capecitabine—Nausea—Vemurafenib—melanoma	0.000116	0.00064	CcSEcCtD
Capecitabine—Thrombocytopenia—Bleomycin—melanoma	0.000116	0.000639	CcSEcCtD
Capecitabine—Vision blurred—Temozolomide—melanoma	0.000115	0.000636	CcSEcCtD
Capecitabine—Myalgia—Dactinomycin—melanoma	0.000115	0.000635	CcSEcCtD
Capecitabine—Bronchospasm—Docetaxel—melanoma	0.000115	0.000633	CcSEcCtD
Capecitabine—Tremor—Temozolomide—melanoma	0.000114	0.000632	CcSEcCtD
Capecitabine—Discomfort—Dactinomycin—melanoma	0.000114	0.000627	CcSEcCtD
Capecitabine—Angina pectoris—Docetaxel—melanoma	0.000114	0.000627	CcSEcCtD
Capecitabine—Ill-defined disorder—Temozolomide—melanoma	0.000113	0.000626	CcSEcCtD
Capecitabine—Leukopenia—Carmustine—melanoma	0.000113	0.000625	CcSEcCtD
Capecitabine—Anaemia—Temozolomide—melanoma	0.000113	0.000623	CcSEcCtD
Capecitabine—Anorexia—Bleomycin—melanoma	0.000113	0.000622	CcSEcCtD
Capecitabine—Pancytopenia—Docetaxel—melanoma	0.000111	0.000611	CcSEcCtD
Capecitabine—Hypotension—Bleomycin—melanoma	0.00011	0.00061	CcSEcCtD
Capecitabine—Oedema—Dactinomycin—melanoma	0.00011	0.000609	CcSEcCtD
Capecitabine—Malaise—Temozolomide—melanoma	0.00011	0.000608	CcSEcCtD
Capecitabine—Vertigo—Temozolomide—melanoma	0.00011	0.000606	CcSEcCtD
Capecitabine—Infection—Dactinomycin—melanoma	0.00011	0.000605	CcSEcCtD
Capecitabine—Leukopenia—Temozolomide—melanoma	0.000109	0.000604	CcSEcCtD
Capecitabine—Hypertension—Carmustine—melanoma	0.000109	0.000603	CcSEcCtD
Capecitabine—Neutropenia—Docetaxel—melanoma	0.000109	0.000602	CcSEcCtD
Capecitabine—Palpitations—Temozolomide—melanoma	0.000108	0.000596	CcSEcCtD
Capecitabine—Thrombocytopenia—Dactinomycin—melanoma	0.000108	0.000596	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000108	0.000594	CcSEcCtD
Capecitabine—Myalgia—Carmustine—melanoma	0.000108	0.000594	CcSEcCtD
Capecitabine—Chest pain—Carmustine—melanoma	0.000108	0.000594	CcSEcCtD
Capecitabine—Anxiety—Carmustine—melanoma	0.000107	0.000592	CcSEcCtD
Capecitabine—Cough—Temozolomide—melanoma	0.000107	0.000589	CcSEcCtD
Capecitabine—Paraesthesia—Bleomycin—melanoma	0.000106	0.000586	CcSEcCtD
Capecitabine—Weight increased—Docetaxel—melanoma	0.000106	0.000586	CcSEcCtD
Capecitabine—Weight decreased—Docetaxel—melanoma	0.000106	0.000582	CcSEcCtD
Capecitabine—Hypertension—Temozolomide—melanoma	0.000106	0.000582	CcSEcCtD
Capecitabine—Dyspnoea—Bleomycin—melanoma	0.000105	0.000582	CcSEcCtD
Capecitabine—Anorexia—Dactinomycin—melanoma	0.000105	0.00058	CcSEcCtD
Capecitabine—Pneumonia—Docetaxel—melanoma	0.000105	0.000577	CcSEcCtD
Capecitabine—Confusional state—Carmustine—melanoma	0.000104	0.000574	CcSEcCtD
Capecitabine—Myalgia—Temozolomide—melanoma	0.000104	0.000574	CcSEcCtD
Capecitabine—Arthralgia—Temozolomide—melanoma	0.000104	0.000574	CcSEcCtD
Capecitabine—Infestation NOS—Docetaxel—melanoma	0.000104	0.000574	CcSEcCtD
Capecitabine—Infestation—Docetaxel—melanoma	0.000104	0.000574	CcSEcCtD
Capecitabine—Anxiety—Temozolomide—melanoma	0.000104	0.000572	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000103	0.00057	CcSEcCtD
Capecitabine—Oedema—Carmustine—melanoma	0.000103	0.00057	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000103	0.000569	CcSEcCtD
Capecitabine—Discomfort—Temozolomide—melanoma	0.000103	0.000567	CcSEcCtD
Capecitabine—Decreased appetite—Bleomycin—melanoma	0.000103	0.000567	CcSEcCtD
Capecitabine—Infection—Carmustine—melanoma	0.000103	0.000566	CcSEcCtD
Capecitabine—Acute coronary syndrome—Docetaxel—melanoma	0.000103	0.000566	CcSEcCtD
Capecitabine—Renal failure—Docetaxel—melanoma	0.000102	0.000564	CcSEcCtD
Capecitabine—Myocardial infarction—Docetaxel—melanoma	0.000102	0.000563	CcSEcCtD
Capecitabine—Neuropathy peripheral—Docetaxel—melanoma	0.000102	0.000563	CcSEcCtD
Capecitabine—Dry mouth—Temozolomide—melanoma	0.000102	0.000562	CcSEcCtD
Capecitabine—Stomatitis—Docetaxel—melanoma	0.000101	0.000559	CcSEcCtD
Capecitabine—Jaundice—Docetaxel—melanoma	0.000101	0.000559	CcSEcCtD
Capecitabine—Pain—Bleomycin—melanoma	0.000101	0.000558	CcSEcCtD
Capecitabine—Conjunctivitis—Docetaxel—melanoma	0.000101	0.000558	CcSEcCtD
Capecitabine—Thrombocytopenia—Carmustine—melanoma	0.000101	0.000558	CcSEcCtD
Capecitabine—Tachycardia—Carmustine—melanoma	0.000101	0.000556	CcSEcCtD
Capecitabine—Confusional state—Temozolomide—melanoma	0.000101	0.000555	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.0001	0.000554	CcSEcCtD
Capecitabine—Oedema—Temozolomide—melanoma	9.97e-05	0.00055	CcSEcCtD
Capecitabine—Infection—Temozolomide—melanoma	9.91e-05	0.000547	CcSEcCtD
Capecitabine—Anorexia—Carmustine—melanoma	9.84e-05	0.000543	CcSEcCtD
Capecitabine—Hepatobiliary disease—Docetaxel—melanoma	9.83e-05	0.000543	CcSEcCtD
Capecitabine—Epistaxis—Docetaxel—melanoma	9.81e-05	0.000541	CcSEcCtD
Capecitabine—Nervous system disorder—Temozolomide—melanoma	9.78e-05	0.00054	CcSEcCtD
Capecitabine—Thrombocytopenia—Temozolomide—melanoma	9.76e-05	0.000539	CcSEcCtD
Capecitabine—Feeling abnormal—Bleomycin—melanoma	9.74e-05	0.000538	CcSEcCtD
Capecitabine—Agranulocytosis—Docetaxel—melanoma	9.7e-05	0.000536	CcSEcCtD
Capecitabine—Skin disorder—Temozolomide—melanoma	9.69e-05	0.000535	CcSEcCtD
Capecitabine—Hypotension—Carmustine—melanoma	9.64e-05	0.000532	CcSEcCtD
Capecitabine—Hyperhidrosis—Temozolomide—melanoma	9.64e-05	0.000532	CcSEcCtD
Capecitabine—Decreased appetite—Dactinomycin—melanoma	9.59e-05	0.000529	CcSEcCtD
Capecitabine—Fatigue—Dactinomycin—melanoma	9.51e-05	0.000525	CcSEcCtD
Capecitabine—Anorexia—Temozolomide—melanoma	9.51e-05	0.000525	CcSEcCtD
Capecitabine—Pain—Dactinomycin—melanoma	9.43e-05	0.00052	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Carmustine—melanoma	9.4e-05	0.000519	CcSEcCtD
Capecitabine—Urticaria—Bleomycin—melanoma	9.39e-05	0.000518	CcSEcCtD
Capecitabine—Haemoglobin—Docetaxel—melanoma	9.38e-05	0.000518	CcSEcCtD
Capecitabine—Rhinitis—Docetaxel—melanoma	9.36e-05	0.000517	CcSEcCtD
Capecitabine—Body temperature increased—Bleomycin—melanoma	9.35e-05	0.000516	CcSEcCtD
Capecitabine—Hepatitis—Docetaxel—melanoma	9.34e-05	0.000515	CcSEcCtD
Capecitabine—Haemorrhage—Docetaxel—melanoma	9.34e-05	0.000515	CcSEcCtD
Capecitabine—Insomnia—Carmustine—melanoma	9.33e-05	0.000515	CcSEcCtD
Capecitabine—Hypoaesthesia—Docetaxel—melanoma	9.29e-05	0.000513	CcSEcCtD
Capecitabine—Paraesthesia—Carmustine—melanoma	9.27e-05	0.000511	CcSEcCtD
Capecitabine—Pharyngitis—Docetaxel—melanoma	9.26e-05	0.000511	CcSEcCtD
Capecitabine—Urinary tract disorder—Docetaxel—melanoma	9.22e-05	0.000509	CcSEcCtD
Capecitabine—Dyspnoea—Carmustine—melanoma	9.2e-05	0.000508	CcSEcCtD
Capecitabine—Oedema peripheral—Docetaxel—melanoma	9.2e-05	0.000508	CcSEcCtD
Capecitabine—Connective tissue disorder—Docetaxel—melanoma	9.17e-05	0.000506	CcSEcCtD
Capecitabine—Urethral disorder—Docetaxel—melanoma	9.15e-05	0.000505	CcSEcCtD
Capecitabine—Feeling abnormal—Dactinomycin—melanoma	9.09e-05	0.000501	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Temozolomide—melanoma	9.09e-05	0.000501	CcSEcCtD
Capecitabine—Insomnia—Temozolomide—melanoma	9.02e-05	0.000498	CcSEcCtD
Capecitabine—Gastrointestinal pain—Dactinomycin—melanoma	9.02e-05	0.000498	CcSEcCtD
Capecitabine—Visual impairment—Docetaxel—melanoma	9e-05	0.000497	CcSEcCtD
Capecitabine—Decreased appetite—Carmustine—melanoma	8.97e-05	0.000495	CcSEcCtD
Capecitabine—Paraesthesia—Temozolomide—melanoma	8.96e-05	0.000494	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Carmustine—melanoma	8.91e-05	0.000492	CcSEcCtD
Capecitabine—Dyspnoea—Temozolomide—melanoma	8.89e-05	0.000491	CcSEcCtD
Capecitabine—Erythema multiforme—Docetaxel—melanoma	8.83e-05	0.000487	CcSEcCtD
Capecitabine—Pain—Carmustine—melanoma	8.83e-05	0.000487	CcSEcCtD
Capecitabine—Constipation—Carmustine—melanoma	8.83e-05	0.000487	CcSEcCtD
Capecitabine—Dyspepsia—Temozolomide—melanoma	8.78e-05	0.000485	CcSEcCtD
Capecitabine—Eye disorder—Docetaxel—melanoma	8.72e-05	0.000481	CcSEcCtD
Capecitabine—Body temperature increased—Dactinomycin—melanoma	8.72e-05	0.000481	CcSEcCtD
Capecitabine—Abdominal pain—Dactinomycin—melanoma	8.72e-05	0.000481	CcSEcCtD
Capecitabine—Hypersensitivity—Bleomycin—melanoma	8.71e-05	0.000481	CcSEcCtD
Capecitabine—Decreased appetite—Temozolomide—melanoma	8.67e-05	0.000478	CcSEcCtD
Capecitabine—Flushing—Docetaxel—melanoma	8.66e-05	0.000478	CcSEcCtD
Capecitabine—Cardiac disorder—Docetaxel—melanoma	8.66e-05	0.000478	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Temozolomide—melanoma	8.61e-05	0.000475	CcSEcCtD
Capecitabine—Fatigue—Temozolomide—melanoma	8.6e-05	0.000475	CcSEcCtD
Capecitabine—Pain—Temozolomide—melanoma	8.53e-05	0.000471	CcSEcCtD
Capecitabine—Constipation—Temozolomide—melanoma	8.53e-05	0.000471	CcSEcCtD
Capecitabine—Feeling abnormal—Carmustine—melanoma	8.5e-05	0.000469	CcSEcCtD
Capecitabine—Asthenia—Bleomycin—melanoma	8.48e-05	0.000468	CcSEcCtD
Capecitabine—Angiopathy—Docetaxel—melanoma	8.47e-05	0.000467	CcSEcCtD
Capecitabine—Gastrointestinal pain—Carmustine—melanoma	8.44e-05	0.000466	CcSEcCtD
Capecitabine—Immune system disorder—Docetaxel—melanoma	8.43e-05	0.000465	CcSEcCtD
Capecitabine—TYMP—Metabolism—CUBN—melanoma	8.42e-05	0.0012	CbGpPWpGaD
Capecitabine—Mediastinal disorder—Docetaxel—melanoma	8.41e-05	0.000464	CcSEcCtD
Capecitabine—CDA—Metabolism—PLA2G6—melanoma	8.38e-05	0.00119	CbGpPWpGaD
Capecitabine—Chills—Docetaxel—melanoma	8.38e-05	0.000462	CcSEcCtD
Capecitabine—Pruritus—Bleomycin—melanoma	8.36e-05	0.000462	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—AKR1B10—melanoma	8.35e-05	0.00118	CbGpPWpGaD
Capecitabine—Arrhythmia—Docetaxel—melanoma	8.34e-05	0.00046	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—MYC—melanoma	8.29e-05	0.00118	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	8.26e-05	0.00117	CbGpPWpGaD
Capecitabine—Alopecia—Docetaxel—melanoma	8.25e-05	0.000455	CcSEcCtD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	8.24e-05	0.00117	CbGpPWpGaD
Capecitabine—Feeling abnormal—Temozolomide—melanoma	8.22e-05	0.000454	CcSEcCtD
Capecitabine—Mental disorder—Docetaxel—melanoma	8.18e-05	0.000451	CcSEcCtD
Capecitabine—Body temperature increased—Carmustine—melanoma	8.16e-05	0.00045	CcSEcCtD
Capecitabine—Abdominal pain—Carmustine—melanoma	8.16e-05	0.00045	CcSEcCtD
Capecitabine—Gastrointestinal pain—Temozolomide—melanoma	8.16e-05	0.00045	CcSEcCtD
Capecitabine—TYMP—Metabolism—SDHD—melanoma	8.13e-05	0.00115	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CSPG4—melanoma	8.13e-05	0.00115	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—BSG—melanoma	8.13e-05	0.00115	CbGpPWpGaD
Capecitabine—Erythema—Docetaxel—melanoma	8.13e-05	0.000449	CcSEcCtD
Capecitabine—Malnutrition—Docetaxel—melanoma	8.13e-05	0.000449	CcSEcCtD
Capecitabine—Hypersensitivity—Dactinomycin—melanoma	8.12e-05	0.000448	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—FAS—melanoma	8.09e-05	0.00115	CbGpPWpGaD
Capecitabine—Dysgeusia—Docetaxel—melanoma	7.96e-05	0.000439	CcSEcCtD
Capecitabine—Urticaria—Temozolomide—melanoma	7.92e-05	0.000437	CcSEcCtD
Capecitabine—Asthenia—Dactinomycin—melanoma	7.91e-05	0.000437	CcSEcCtD
Capecitabine—Body temperature increased—Temozolomide—melanoma	7.88e-05	0.000435	CcSEcCtD
Capecitabine—Abdominal pain—Temozolomide—melanoma	7.88e-05	0.000435	CcSEcCtD
Capecitabine—TYMP—Metabolism—GPAM—melanoma	7.88e-05	0.00112	CbGpPWpGaD
Capecitabine—Back pain—Docetaxel—melanoma	7.86e-05	0.000434	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—CDKN1B—melanoma	7.86e-05	0.00112	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	7.84e-05	0.00111	CbGpPWpGaD
Capecitabine—Muscle spasms—Docetaxel—melanoma	7.81e-05	0.000431	CcSEcCtD
Capecitabine—TYMS—Metabolism—UGT2B10—melanoma	7.79e-05	0.00111	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	7.72e-05	0.0011	CbGpPWpGaD
Capecitabine—Hypersensitivity—Carmustine—melanoma	7.6e-05	0.00042	CcSEcCtD
Capecitabine—Diarrhoea—Dactinomycin—melanoma	7.54e-05	0.000416	CcSEcCtD
Capecitabine—CDA—Metabolism—VCAN—melanoma	7.53e-05	0.00107	CbGpPWpGaD
Capecitabine—Vomiting—Bleomycin—melanoma	7.52e-05	0.000415	CcSEcCtD
Capecitabine—Anaemia—Docetaxel—melanoma	7.51e-05	0.000415	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—melanoma	7.48e-05	0.00106	CbGpPWpGaD
Capecitabine—Rash—Bleomycin—melanoma	7.45e-05	0.000411	CcSEcCtD
Capecitabine—Dermatitis—Bleomycin—melanoma	7.45e-05	0.000411	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ATM—melanoma	7.44e-05	0.00106	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	7.41e-05	0.00105	CbGpPWpGaD
Capecitabine—Asthenia—Carmustine—melanoma	7.4e-05	0.000409	CcSEcCtD
Capecitabine—Hypersensitivity—Temozolomide—melanoma	7.35e-05	0.000406	CcSEcCtD
Capecitabine—Syncope—Docetaxel—melanoma	7.29e-05	0.000402	CcSEcCtD
Capecitabine—Leukopenia—Docetaxel—melanoma	7.27e-05	0.000401	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—CDKN1A—melanoma	7.25e-05	0.00103	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HS3ST5—melanoma	7.25e-05	0.00103	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—melanoma	7.2e-05	0.00102	CbGpPWpGaD
Capecitabine—Palpitations—Docetaxel—melanoma	7.18e-05	0.000396	CcSEcCtD
Capecitabine—Asthenia—Temozolomide—melanoma	7.16e-05	0.000395	CcSEcCtD
Capecitabine—Loss of consciousness—Docetaxel—melanoma	7.14e-05	0.000394	CcSEcCtD
Capecitabine—DPYD—Metabolism—CYP17A1—melanoma	7.12e-05	0.00101	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—CDK4—melanoma	7.12e-05	0.00101	CbGpPWpGaD
Capecitabine—Cough—Docetaxel—melanoma	7.09e-05	0.000391	CcSEcCtD
Capecitabine—Diarrhoea—Carmustine—melanoma	7.06e-05	0.00039	CcSEcCtD
Capecitabine—Pruritus—Temozolomide—melanoma	7.06e-05	0.000389	CcSEcCtD
Capecitabine—Nausea—Bleomycin—melanoma	7.02e-05	0.000388	CcSEcCtD
Capecitabine—Hypertension—Docetaxel—melanoma	7.02e-05	0.000387	CcSEcCtD
Capecitabine—Vomiting—Dactinomycin—melanoma	7.01e-05	0.000387	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—SKP2—melanoma	6.98e-05	0.000991	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—APC—melanoma	6.98e-05	0.00099	CbGpPWpGaD
Capecitabine—Rash—Dactinomycin—melanoma	6.95e-05	0.000384	CcSEcCtD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	6.94e-05	0.000984	CbGpPWpGaD
Capecitabine—Chest pain—Docetaxel—melanoma	6.92e-05	0.000382	CcSEcCtD
Capecitabine—Arthralgia—Docetaxel—melanoma	6.92e-05	0.000382	CcSEcCtD
Capecitabine—Myalgia—Docetaxel—melanoma	6.92e-05	0.000382	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—NOS2—melanoma	6.92e-05	0.000982	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGF—melanoma	6.9e-05	0.000979	CbGpPWpGaD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	6.87e-05	0.000379	CcSEcCtD
Capecitabine—Dizziness—Carmustine—melanoma	6.82e-05	0.000377	CcSEcCtD
Capecitabine—Diarrhoea—Temozolomide—melanoma	6.82e-05	0.000377	CcSEcCtD
Capecitabine—Dry mouth—Docetaxel—melanoma	6.77e-05	0.000373	CcSEcCtD
Capecitabine—DPYD—Metabolism—GNA11—melanoma	6.73e-05	0.000955	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PLA2G6—melanoma	6.7e-05	0.000951	CbGpPWpGaD
Capecitabine—Confusional state—Docetaxel—melanoma	6.69e-05	0.000369	CcSEcCtD
Capecitabine—Oedema—Docetaxel—melanoma	6.63e-05	0.000366	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—melanoma	6.62e-05	0.00094	CbGpPWpGaD
Capecitabine—Dizziness—Temozolomide—melanoma	6.59e-05	0.000364	CcSEcCtD
Capecitabine—Infection—Docetaxel—melanoma	6.59e-05	0.000364	CcSEcCtD
Capecitabine—DPYD—Metabolism—FASN—melanoma	6.58e-05	0.000934	CbGpPWpGaD
Capecitabine—Vomiting—Carmustine—melanoma	6.56e-05	0.000362	CcSEcCtD
Capecitabine—Nausea—Dactinomycin—melanoma	6.55e-05	0.000361	CcSEcCtD
Capecitabine—Shock—Docetaxel—melanoma	6.52e-05	0.00036	CcSEcCtD
Capecitabine—Rash—Carmustine—melanoma	6.51e-05	0.000359	CcSEcCtD
Capecitabine—Nervous system disorder—Docetaxel—melanoma	6.5e-05	0.000359	CcSEcCtD
Capecitabine—Dermatitis—Carmustine—melanoma	6.5e-05	0.000359	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	6.5e-05	0.000922	CbGpPWpGaD
Capecitabine—Thrombocytopenia—Docetaxel—melanoma	6.49e-05	0.000358	CcSEcCtD
Capecitabine—DPYD—Metabolism—SLC5A5—melanoma	6.48e-05	0.000919	CbGpPWpGaD
Capecitabine—Tachycardia—Docetaxel—melanoma	6.47e-05	0.000357	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—PPARG—melanoma	6.47e-05	0.000917	CbGpPWpGaD
Capecitabine—Headache—Carmustine—melanoma	6.47e-05	0.000357	CcSEcCtD
Capecitabine—Skin disorder—Docetaxel—melanoma	6.44e-05	0.000356	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	6.39e-05	0.000907	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—AURKA—melanoma	6.38e-05	0.000906	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP17A1—melanoma	6.35e-05	0.000901	CbGpPWpGaD
Capecitabine—Vomiting—Temozolomide—melanoma	6.34e-05	0.00035	CcSEcCtD
Capecitabine—Anorexia—Docetaxel—melanoma	6.32e-05	0.000349	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND1—melanoma	6.32e-05	0.000897	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MLH1—melanoma	6.31e-05	0.000896	CbGpPWpGaD
Capecitabine—Rash—Temozolomide—melanoma	6.29e-05	0.000347	CcSEcCtD
Capecitabine—Dermatitis—Temozolomide—melanoma	6.28e-05	0.000347	CcSEcCtD
Capecitabine—DPYD—Metabolism—GNAQ—melanoma	6.26e-05	0.000888	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CD44—melanoma	6.26e-05	0.000888	CbGpPWpGaD
Capecitabine—Headache—Temozolomide—melanoma	6.25e-05	0.000345	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—SKP2—melanoma	6.24e-05	0.000886	CbGpPWpGaD
Capecitabine—Hypotension—Docetaxel—melanoma	6.2e-05	0.000342	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	6.17e-05	0.000876	CbGpPWpGaD
Capecitabine—Nausea—Carmustine—melanoma	6.13e-05	0.000338	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1A—melanoma	6.11e-05	0.000867	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Docetaxel—melanoma	6.04e-05	0.000333	CcSEcCtD
Capecitabine—TYMP—Metabolism—VCAN—melanoma	6.02e-05	0.000854	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—melanoma	6.01e-05	0.000853	CbGpPWpGaD
Capecitabine—Insomnia—Docetaxel—melanoma	6e-05	0.000331	CcSEcCtD
Capecitabine—DPYD—Metabolism—CYP1B1—melanoma	6e-05	0.000851	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GNA11—melanoma	6e-05	0.000851	CbGpPWpGaD
Capecitabine—Paraesthesia—Docetaxel—melanoma	5.96e-05	0.000329	CcSEcCtD
Capecitabine—Nausea—Temozolomide—melanoma	5.92e-05	0.000327	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—melanoma	5.91e-05	0.000839	CbGpPWpGaD
Capecitabine—Dyspnoea—Docetaxel—melanoma	5.91e-05	0.000326	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	5.87e-05	0.000833	CbGpPWpGaD
Capecitabine—CDA—Metabolism—FASN—melanoma	5.87e-05	0.000833	CbGpPWpGaD
Capecitabine—Dyspepsia—Docetaxel—melanoma	5.84e-05	0.000322	CcSEcCtD
Capecitabine—CDA—Metabolism—SLC5A5—melanoma	5.77e-05	0.000819	CbGpPWpGaD
Capecitabine—Decreased appetite—Docetaxel—melanoma	5.77e-05	0.000318	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Docetaxel—melanoma	5.73e-05	0.000316	CcSEcCtD
Capecitabine—Fatigue—Docetaxel—melanoma	5.72e-05	0.000316	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—AURKA—melanoma	5.71e-05	0.00081	CbGpPWpGaD
Capecitabine—Constipation—Docetaxel—melanoma	5.67e-05	0.000313	CcSEcCtD
Capecitabine—Pain—Docetaxel—melanoma	5.67e-05	0.000313	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	5.58e-05	0.000791	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GNAQ—melanoma	5.58e-05	0.000791	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CD44—melanoma	5.58e-05	0.000791	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—APEX1—melanoma	5.55e-05	0.000787	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ACER3—melanoma	5.52e-05	0.000783	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	5.5e-05	0.00078	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PLCB4—melanoma	5.49e-05	0.000779	CbGpPWpGaD
Capecitabine—Feeling abnormal—Docetaxel—melanoma	5.47e-05	0.000302	CcSEcCtD
Capecitabine—Gastrointestinal pain—Docetaxel—melanoma	5.42e-05	0.000299	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	5.42e-05	0.000769	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP1B1—melanoma	5.35e-05	0.000759	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	5.3e-05	0.000752	CbGpPWpGaD
Capecitabine—Abdominal pain—Docetaxel—melanoma	5.24e-05	0.000289	CcSEcCtD
Capecitabine—Body temperature increased—Docetaxel—melanoma	5.24e-05	0.000289	CcSEcCtD
Capecitabine—TYMS—Metabolism—SLC6A11—melanoma	5.16e-05	0.000733	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIP4K2A—melanoma	5.16e-05	0.000733	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP17A1—melanoma	5.08e-05	0.00072	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—melanoma	5.07e-05	0.000719	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTAP—melanoma	5.02e-05	0.000713	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	5.02e-05	0.000712	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—APEX1—melanoma	4.96e-05	0.000704	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ABCB1—melanoma	4.94e-05	0.000701	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	4.92e-05	0.000698	CbGpPWpGaD
Capecitabine—Hypersensitivity—Docetaxel—melanoma	4.89e-05	0.00027	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—melanoma	4.8e-05	0.000681	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GNA11—melanoma	4.79e-05	0.00068	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	4.79e-05	0.000679	CbGpPWpGaD
Capecitabine—Asthenia—Docetaxel—melanoma	4.76e-05	0.000263	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	4.74e-05	0.000673	CbGpPWpGaD
Capecitabine—Pruritus—Docetaxel—melanoma	4.69e-05	0.000259	CcSEcCtD
Capecitabine—TYMP—Metabolism—FASN—melanoma	4.69e-05	0.000666	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	4.63e-05	0.000657	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	4.62e-05	0.000656	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC5A5—melanoma	4.62e-05	0.000655	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.6e-05	0.000652	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PRKCA—melanoma	4.55e-05	0.000645	CbGpPWpGaD
Capecitabine—Diarrhoea—Docetaxel—melanoma	4.54e-05	0.00025	CcSEcCtD
Capecitabine—DPYD—Metabolism—ERCC2—melanoma	4.51e-05	0.00064	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LUM—melanoma	4.48e-05	0.000635	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PHGDH—melanoma	4.48e-05	0.000635	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	4.46e-05	0.000633	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GNAQ—melanoma	4.46e-05	0.000633	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CD44—melanoma	4.46e-05	0.000633	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PTEN—melanoma	4.44e-05	0.000629	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—E2F1—melanoma	4.4e-05	0.000625	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ABCB1—melanoma	4.4e-05	0.000625	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HPSE—melanoma	4.39e-05	0.000623	CbGpPWpGaD
Capecitabine—Dizziness—Docetaxel—melanoma	4.39e-05	0.000242	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP17A1—melanoma	4.38e-05	0.000621	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	4.32e-05	0.000613	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PRKCA—melanoma	4.31e-05	0.000612	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CUBN—melanoma	4.31e-05	0.000611	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2B—melanoma	4.29e-05	0.000609	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP1B1—melanoma	4.27e-05	0.000606	CbGpPWpGaD
Capecitabine—Vomiting—Docetaxel—melanoma	4.22e-05	0.000233	CcSEcCtD
Capecitabine—Rash—Docetaxel—melanoma	4.18e-05	0.000231	CcSEcCtD
Capecitabine—Dermatitis—Docetaxel—melanoma	4.18e-05	0.000231	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4.17e-05	0.000592	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SDHD—melanoma	4.16e-05	0.000591	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—BSG—melanoma	4.16e-05	0.000591	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CSPG4—melanoma	4.16e-05	0.000591	CbGpPWpGaD
Capecitabine—Headache—Docetaxel—melanoma	4.15e-05	0.000229	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—PCNA—melanoma	4.15e-05	0.000589	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PRKCA—melanoma	4.05e-05	0.000575	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GPAM—melanoma	4.03e-05	0.000572	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ERCC2—melanoma	4.02e-05	0.00057	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.95e-05	0.00056	CbGpPWpGaD
Capecitabine—Nausea—Docetaxel—melanoma	3.94e-05	0.000217	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—E2F1—melanoma	3.94e-05	0.000559	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PRKCA—melanoma	3.86e-05	0.000547	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.84e-05	0.000545	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK2—melanoma	3.8e-05	0.000539	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.76e-05	0.000533	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.76e-05	0.000533	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PCNA—melanoma	3.71e-05	0.000527	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP1B1—melanoma	3.68e-05	0.000523	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	3.63e-05	0.000516	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK4—melanoma	3.59e-05	0.000509	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TERT—melanoma	3.58e-05	0.000509	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.58e-05	0.000508	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CG—melanoma	3.56e-05	0.000505	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.55e-05	0.000503	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ABCB1—melanoma	3.52e-05	0.000499	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPARG—melanoma	3.44e-05	0.000488	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PLA2G6—melanoma	3.43e-05	0.000486	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK2—melanoma	3.39e-05	0.000482	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	3.34e-05	0.000474	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.26e-05	0.000463	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PRKCA—melanoma	3.24e-05	0.00046	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—ATM—melanoma	3.22e-05	0.000457	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ERCC2—melanoma	3.21e-05	0.000456	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK4—melanoma	3.21e-05	0.000455	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CG—melanoma	3.17e-05	0.00045	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.15e-05	0.000447	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CD—melanoma	3.13e-05	0.000444	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RB1—melanoma	3.12e-05	0.000443	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ALB—melanoma	3.09e-05	0.000438	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—VCAN—melanoma	3.08e-05	0.000437	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPARG—melanoma	3.06e-05	0.000435	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—melanoma	3.03e-05	0.00043	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RB1—melanoma	2.79e-05	0.000396	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CD—melanoma	2.79e-05	0.000396	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	2.79e-05	0.000396	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—melanoma	2.77e-05	0.000393	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—melanoma	2.75e-05	0.000391	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—melanoma	2.74e-05	0.000389	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CB—melanoma	2.73e-05	0.000387	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTGS2—melanoma	2.7e-05	0.000384	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.66e-05	0.000378	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	2.61e-05	0.00037	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP17A1—melanoma	2.6e-05	0.000369	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CG—melanoma	2.54e-05	0.00036	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ACER3—melanoma	2.46e-05	0.000349	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GNA11—melanoma	2.45e-05	0.000348	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2A—melanoma	2.45e-05	0.000348	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARG—melanoma	2.45e-05	0.000347	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CB—melanoma	2.43e-05	0.000345	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—melanoma	2.43e-05	0.000345	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS2—melanoma	2.41e-05	0.000342	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—FASN—melanoma	2.4e-05	0.000341	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MDM2—melanoma	2.38e-05	0.000338	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC5A5—melanoma	2.36e-05	0.000335	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTEN—melanoma	2.36e-05	0.000335	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—melanoma	2.32e-05	0.000329	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GNAQ—melanoma	2.28e-05	0.000324	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CD44—melanoma	2.28e-05	0.000324	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UGT2B10—melanoma	2.25e-05	0.000319	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—melanoma	2.24e-05	0.000318	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CD—melanoma	2.23e-05	0.000316	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.22e-05	0.000315	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALB—melanoma	2.2e-05	0.000312	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP1B1—melanoma	2.19e-05	0.00031	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1B—melanoma	2.17e-05	0.000308	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTEN—melanoma	2.1e-05	0.000298	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HS3ST5—melanoma	2.09e-05	0.000296	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND1—melanoma	2.07e-05	0.000294	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1A—melanoma	2e-05	0.000284	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CB—melanoma	1.94e-05	0.000276	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTGS2—melanoma	1.93e-05	0.000273	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK3—melanoma	1.91e-05	0.000271	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—melanoma	1.86e-05	0.000264	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK1—melanoma	1.82e-05	0.000258	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCB1—melanoma	1.8e-05	0.000255	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAPK3—melanoma	1.71e-05	0.000242	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.68e-05	0.000239	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTEN—melanoma	1.68e-05	0.000238	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—melanoma	1.66e-05	0.000236	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—melanoma	1.66e-05	0.000236	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PRKCA—melanoma	1.66e-05	0.000235	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ERCC2—melanoma	1.64e-05	0.000233	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAPK1—melanoma	1.63e-05	0.000231	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLCB4—melanoma	1.58e-05	0.000225	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	1.55e-05	0.00022	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC6A11—melanoma	1.49e-05	0.000211	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIP4K2A—melanoma	1.49e-05	0.000211	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CA—melanoma	1.48e-05	0.00021	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTAP—melanoma	1.45e-05	0.000205	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.41e-05	0.000201	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—melanoma	1.36e-05	0.000194	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—melanoma	1.36e-05	0.000193	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CG—melanoma	1.3e-05	0.000184	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PHGDH—melanoma	1.29e-05	0.000183	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LUM—melanoma	1.29e-05	0.000183	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HPSE—melanoma	1.27e-05	0.00018	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARG—melanoma	1.25e-05	0.000178	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CUBN—melanoma	1.24e-05	0.000176	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—melanoma	1.21e-05	0.000172	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SDHD—melanoma	1.2e-05	0.00017	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CSPG4—melanoma	1.2e-05	0.00017	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BSG—melanoma	1.2e-05	0.00017	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CA—melanoma	1.18e-05	0.000168	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPAM—melanoma	1.16e-05	0.000165	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CD—melanoma	1.14e-05	0.000162	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—melanoma	1.13e-05	0.00016	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CB—melanoma	9.94e-06	0.000141	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLA2G6—melanoma	9.88e-06	0.00014	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—melanoma	9.85e-06	0.00014	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—melanoma	9.68e-06	0.000137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—VCAN—melanoma	8.87e-06	0.000126	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTEN—melanoma	8.59e-06	0.000122	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.4e-06	0.000119	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.11e-06	0.000115	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP17A1—melanoma	7.49e-06	0.000106	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.38e-06	0.000105	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	7.29e-06	0.000103	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GNA11—melanoma	7.07e-06	0.0001	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—FASN—melanoma	6.92e-06	9.82e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC5A5—melanoma	6.81e-06	9.66e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GNAQ—melanoma	6.57e-06	9.33e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CD44—melanoma	6.57e-06	9.33e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.44e-06	9.13e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.38e-06	9.05e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1B1—melanoma	6.3e-06	8.94e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—melanoma	6.06e-06	8.6e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.56e-06	7.89e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCB1—melanoma	5.19e-06	7.36e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—melanoma	4.95e-06	7.03e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PRKCA—melanoma	4.78e-06	6.78e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ERCC2—melanoma	4.74e-06	6.72e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.92e-06	5.57e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—melanoma	3.74e-06	5.31e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARG—melanoma	3.61e-06	5.12e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CD—melanoma	3.29e-06	4.67e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—melanoma	3.25e-06	4.61e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CB—melanoma	2.87e-06	4.07e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—melanoma	2.84e-06	4.03e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—melanoma	2.48e-06	3.51e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—melanoma	1.75e-06	2.48e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—melanoma	1.43e-06	2.03e-05	CbGpPWpGaD
